Leukemia, Prolymphocytic
Showing 26 - 50 of 5,253
NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)
Completed
- NHL
- +17 more
- veltuzumab
-
Savannah, Georgia
- +4 more
Aug 12, 2021
Anemia, B-Cell Prolymphocytic Leukemia, Grade 1 Follicular Lymphoma Trial in Portland (drug, other, biological)
Completed
- Anemia
- +13 more
- Entospletinib
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Apr 29, 2021
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,
Recruiting
- Acute Myelogenous Leukemia
- +17 more
- Allopurinol
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
May 21, 2021
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)
Terminated
- Acute Lymphoblastic Leukemia
- +17 more
- Infusion of Treg
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Sep 8, 2020
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,
Completed
- Acute Myeloid Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, Minnesota
- +1 more
Sep 9, 2020
Anemia, Cancer Fatigue, Chronic Lymphocytic Leukemia Trial in Houston (Ex Vivo-activated Autologous Lymph Node Lymphocytes,
Completed
- Anemia
- +13 more
- Ex Vivo-activated Autologous Lymph Node Lymphocytes
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 7, 2019
Prolymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma Trial in Salt Lake City,
Completed
- Prolymphocytic Leukemia
- +13 more
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Salt Lake City, Utah
- +4 more
Jan 17, 2020
Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Chronic Lymphocytic Leukemia Trial in
Completed
- Aggressive Non-Hodgkin Lymphoma
- +20 more
- Atorvastatin Calcium
- +7 more
-
Denver, Colorado
- +1 more
Dec 26, 2019
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Denmark, Germany, United States
Completed
- Acute Lymphoblastic Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +6 more
-
Denver, Colorado
- +10 more
Oct 10, 2019
Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia Trial
Completed
- Hematopoietic/Lymphoid Cancer
- +22 more
- CART-19
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Jun 21, 2019
B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p Trial in Seattle, Milwaukee (procedure, drug, other,
Completed
- B-Cell Prolymphocytic Leukemia
- +20 more
- Allogeneic Bone Marrow Transplantation
- +14 more
-
Seattle, Washington
- +1 more
May 31, 2019
Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Denmark, Italy, United
Completed
- Chronic Lymphocytic Leukemia
- +8 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Rochester, Minnesota
- +4 more
Jun 20, 2019
Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)
Not yet recruiting
- Leukemia
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 28, 2023
Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)
Recruiting
- Hematologic Malignancies
- Haplo HCT <55 years old
- +4 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 25, 2023
Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)
Active, not recruiting
- Waldenstrom's Macroglobulinemia
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 20, 2022
Leukemia, Acute Lymphocytic Leukemia Trial in Stanford (Velcade)
Withdrawn
- Leukemia
- Acute Lymphocytic Leukemia
-
Stanford, CaliforniaStanford University School of Medicine
May 16, 2018
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)
Recruiting
- Brain and Central Nervous System Tumors
- +8 more
- 3'-deoxy-3'-[18F]fluorothymidine
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 30, 2022
Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)
Completed
- Brain and Central Nervous System Tumors
- +10 more
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021
Tissue, Blood, and Body Fluid Sample Collection From Hematologic
Recruiting
- Chronic Myeloproliferative Disorders
- +7 more
- biologic sample preservation procedure
- cytology specimen collection procedure
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Oct 14, 2021
B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in France, United States (XmAb13676)
Recruiting
- B-cell Non-Hodgkins Lymphoma
- Chronic Lymphocytic Leukemia
- XmAb13676
-
La Jolla, California
- +21 more
Oct 20, 2021
Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)
Active, not recruiting
- Waldenstrom Macroglobulinemia
- MYD88 Gene Mutation
-
Boston, Massachusetts
- +1 more
Apr 1, 2022
Collecting and Storing Blood Samples From Patients With Cancer
Withdrawn
- Brain and Central Nervous System Tumors
- +10 more
- (no location specified)
Sep 20, 2021
Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)
Active, not recruiting
- Relapsed Adult ALL
- Relapsed Adult AML
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 19, 2023